Cytokine gene expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein.

To extent our knowledge on the cytokines possibly involved in the pathophysiology of B-cell chronic lymphocytic leukemia (B-CLL), the mRNA expression of a panel of 10 cytokines was investigated on purified B-CLL cells using a reverse-transcriptase polymerase chain reaction method. Whereas negative RT-PCR signals were recorded for interleukin-1 alpha (IL-1 alpha), IL-2, IL-3, IL-4, IL-5, IL-7, tumor necrosis factor beta (TNF beta), and granulocyte-macrophage colony-stimulating factor, we detected the expression of IL-1 beta, IL-6 and TNF alpha. Furthermore, the constitutive expression of IL-8 mRNA was observed in all 17 B-CLL samples analyzed. mRNA expression was associated with the capacity of the leukemic cells to release IL-8 both constitutively (4.6 +/- 8.1 SD ng/mL) and, to a further extent, after stimulation (14.5 +/- 19.4 ng/mL). The circulating levels of IL-8 were also evaluated in 12 untreated B-CLL sera samples and the overall mean level was significantly higher (P < .01) than in normal sera. In addition, supernatants of purified B-CLL cells cultured in the presence of 12-O-tetradecanoylphorbol-13-acetate showed chemotactic activity towards neutrophils; this activity was neutralized in the presence of an anti-IL-8 antiserum. The mRNA for IL-8 was absent in five B-cell preparations from hairy cell leukemia cases and in four B-cell lines. Normal tonsil CD5+ B cells showed a low expression of IL-8 mRNA only in two of the nine preparations tested and the overall quantity of IL-8 released by these cells after 3 days' incubation was significantly lower compared with that released by B-CLL cells (0.4 +/- 0.3 and 1.6 +/- 0.9 ng/mL under basal and stimulated conditions, respectively). These findings point to an involvement of a member of the proinflammatory chemokine supergene family in human CD5+ B lymphocytes. The different IL-8 behavior observed between B-CLL cells and their normal counterpart is likely to reflect an activation state of the leukemic population.

[1]  M. Fey,et al.  Constitutive expression of interleukin-8 and its receptor in human myeloid and lymphoid leukemia , 1993 .

[2]  J. Frishman,et al.  Genes for Interleukin 7 Are Transcribed in Leukemic Cell Subsets of Hdividuak with Chronic Lymphocytic Leukemia , 1993 .

[3]  D. Wallach,et al.  Aderka, D. et al. Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor- or -. Blood 81, 2076−2084 , 1993 .

[4]  D. Wallach,et al.  Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -beta. , 1993, Blood.

[5]  H. Mikawa,et al.  Interleukin 8 (IL-8) selectively inhibits immunoglobulin E production induced by IL-4 in human B cells , 1992, The Journal of experimental medicine.

[6]  A. Mantovani,et al.  Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells , 1992, The Journal of experimental medicine.

[7]  M. Dono,et al.  Production of granulocyte-macrophage colony-stimulating factor but not IL-3 by normal and neoplastic human B lymphocytes. , 1992, Journal of immunology.

[8]  A. Mantovani,et al.  Expression of Adhesion Molecules and Chemotactic Cytokines in Cultured Human Mesothelial Cells By Nives Jonji6,* Giuseppe Peri,* Sergio Bernasconi,* , 1992 .

[9]  P. Carré,et al.  Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. A potential mechanism for the recruitment and activation of neutrophils in lung fibrosis. , 1991, The Journal of clinical investigation.

[10]  S. Chevret,et al.  B-cell chronic lymphocytic leukemia: present status and future directions. French Cooperative Group on CLL. , 1991, Blood.

[11]  R. Strieter,et al.  Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. , 1991, Journal of immunology.

[12]  A. J. Valente,et al.  Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. , 1991, The Journal of clinical investigation.

[13]  K. Matsushima,et al.  Expression and secretion of leukocyte chemotactic cytokines by normal human melanocytes and melanoma cells. , 1991, The Journal of investigative dermatology.

[14]  K. Matsushima,et al.  Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints. , 1991, Lymphokine and cytokine research.

[15]  M. Cybulsky,et al.  Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. , 1991, Journal of immunology.

[16]  M. Smyth,et al.  IL-8 gene expression and production in human peripheral blood lymphocyte subsets. , 1991, Journal of immunology.

[17]  B. Andersson,et al.  Expression of interleukin-1 alpha, interleukin-1 beta and interleukin-6 in chronic B lymphocytic leukaemia (B-CLL) cells from patients at different stages of disease progression. , 1991, Clinical and experimental immunology.

[18]  N. Chiorazzi,et al.  Evidence for differential responsiveness of human CD5+ and CD5− B cell subsets to T cell‐independent mitogens , 1991, European journal of immunology.

[19]  K. Matsushima,et al.  Properties of the novel proinflammatory supergene "intercrine" cytokine family. , 1991, Annual review of immunology.

[20]  R. Foà,et al.  Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease. , 1990, Blood.

[21]  A. Mantovani,et al.  Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8. , 1990, Biochemical and biophysical research communications.

[22]  A. Sica,et al.  IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells. , 1990, Immunology.

[23]  R. Strieter,et al.  Cytokine-induced gene expression of a neutrophil chemotactic factor/IL-8 in human hepatocytes. , 1990, Journal of immunology.

[24]  G. Opdenakker,et al.  Characterization of granulocyte chemotactic activity from human cytokine-stimulated chondrocytes as interleukin 8. , 1990, Cytokine.

[25]  E. Leonard,et al.  Leukocyte specificity and binding of human neutrophil attractant/activation protein-1. , 1990, Journal of immunology.

[26]  T. Standiford,et al.  Disparate gene expression of chemotactic cytokines by human mononuclear phagocytes. , 1990, Biochemical and biophysical research communications.

[27]  K. Matsushima,et al.  Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. , 1989, Cytokine.

[28]  M. Baggiolini,et al.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. , 1989, The Journal of clinical investigation.

[29]  K. Matsushima,et al.  Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor. , 1989, Immunology.

[30]  G. Opdenakker,et al.  The chemotactic activity for granulocytes produced by virally infected fibroblasts is identical to monocyte‐derived interleukin 8 , 1989, European journal of immunology.

[31]  K. Nilsson,et al.  Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B‐type chronic lymphocytic leukemia cells depending on the costimulatory activation and progression signals , 1989, European journal of immunology.

[32]  T. Barbui,et al.  Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia. , 1989, Blood.

[33]  H. Heimpel,et al.  Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia. , 1989, Blood.

[34]  E. Appella,et al.  The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. , 1989, Science.

[35]  R. Strieter,et al.  Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. , 1989, Science.

[36]  K. Matsushima,et al.  Brief Definitive Report Identification and Characterization of Specific Receptors for Monocyte-derived Neutrophil Chemotactic Factor (mdncf) on Human Neutrophils , 2022 .

[37]  D L Simmons,et al.  Monocyte antigen CD14 is a phospholipid anchored membrane protein. , 1989, Blood.

[38]  E. Appella,et al.  Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor , 1988, The Journal of experimental medicine.

[39]  M. Turner,et al.  TUMOUR NECROSIS FACTOR AS AN AUTOCRINE TUMOUR GROWTH FACTOR FOR CHRONIC B-CELL MALIGNANCIES , 1988, The Lancet.

[40]  L. Buluwela,et al.  Physical linkage of three CD3 genes on human chromosome 11. , 1987, The EMBO journal.

[41]  F. Bieber,et al.  Normal cellular counterparts of B cell chronic lymphocytic leukemia. , 1987, Blood.

[42]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[43]  M. Ferrarini,et al.  In vitro production of interleukin 1 by normal and malignant human B lymphocytes. , 1986, Journal of immunology.

[44]  J. Strominger,et al.  Isolation of complementary DNA clones encoding the human lymphocyte glycoprotein T1/Leu-1 , 1986, Nature.

[45]  P. Thomas,et al.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. , 1980, Proceedings of the National Academy of Sciences of the United States of America.